Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
UCB Exercises Tozadenant Option But Asks Biotie To Move It To Phase III
Feb 27 2013
•
By
John Davis
More from Archive
More from Pink Sheet